Medically reviewed by W. van Donselaar, doctor, BIG 79020681301, on 29 October 2026.
Perhaps you’re taking Ozempic or another medicine containing semaglutide and are thinking about having a baby. Or you might discover you’re pregnant whilst you’re still on the treatment. It’s only natural that questions will arise. Can you use Ozempic during pregnancy? When should you stop if you’re planning to get pregnant? And what impact will temporarily stopping have on your weight?
There is a great deal of uncertainty surrounding Ozempic and pregnancy. Online, you’ll find stories about unexpected pregnancies, but also concerns about the safety of the baby. In this blog, you’ll find out what the official guidelines say and what research has shown so far. You’ll also learn how to prepare properly for pregnancy if you’re taking semaglutide. Finally, you’ll find out what to look out for after giving birth.
The short answer
You must not use Ozempic during pregnancy. There is insufficient data on its safety in pregnant women. Adverse effects have been observed in animal studies. If you are planning to become pregnant, you are advised to stop taking semaglutide at least two months before you plan to conceive, as the medicine remains in your body for a long time. If you become pregnant unexpectedly, stop taking the medicine and contact your doctor. Research to date does not indicate a significantly increased risk, but caution remains the guiding principle. Ozempic is also not recommended whilst breastfeeding.
Table of Contents
- Can you take Ozempic whilst pregnant?
- Ozempic and trying for a baby: how do you prepare?
- Ozempic after pregnancy
- Practical advice on Ozempic and planning a family
- Frequently asked questions
- Key insights
Would you like to work towards a healthier weight, for example as part of preparing to start a family? At WeightConsult, a doctor will assess on a one-to-one basis whether medical support is suitable for you and your plans.
Can you take Ozempic whilst pregnant?
No. Using Ozempic during pregnancy is not recommended. This is stated in the official product information from the European Medicines Agency (EMA). To understand why, it is helpful to first know how the medicine works.
What is Ozempic?
Ozempic contains the active ingredient semaglutide. This is a GLP-1 agonist: a medicine that mimics the body’s own hormone, GLP-1. GLP-1 is normally released after eating. It helps your pancreas to produce insulin when your blood sugar rises. It slows down the emptying of the stomach. It also signals to your brain that you are full.
Ozempic is authorised in the Netherlands for the treatment of type 2 diabetes. For medical weight management, the same active ingredient is prescribed under the name Wegovy, in a different dosage. What you read in this blog about pregnancy applies to semaglutide in general. It therefore applies to both medicines.
Why semaglutide is not used during pregnancy
There are three reasons why doctors advise against taking semaglutide during pregnancy.
There is not enough data. Medicines are almost never tested on pregnant women. As a result, little is known about the effects of semaglutide on an unborn child. What is known comes mainly from animal studies and retrospective observational studies.
Adverse effects have been observed in animal studies. In animal studies, semaglutide has been linked to problems with foetal development. Animal studies cannot be directly applied to humans. Nevertheless, it is a reason to exercise caution.
Losing weight is not the aim during pregnancy. A growing baby needs a constant supply of nutrients. Semaglutide suppresses your appetite and can cause nausea and vomiting. This is not ideal during a period when your body actually needs extra energy and nutrition. Even if you are overweight, the aim during pregnancy is not to lose weight, but to avoid gaining too much.
What does research say about safety for the baby?
As more and more women are taking GLP-1 medication, larger studies have now been carried out into pregnancies where the mother was still taking the drug at the start. This was often because she was not yet aware that she was pregnant.
An international study published in 2024 in *JAMA Internal Medicine* followed more than 51,000 pregnancies in women with type 2 diabetes. The researchers compared women who were taking GLP-1 medication around the time of conception with women who were taking insulin. They found no clear increased risk of serious congenital abnormalities.
In June 2026, a US study involving over 3,500 pregnancies was published in the *Annals of Internal Medicine*. The study looked at women who used GLP-1 medication during the first trimester, compared with women who had stopped taking it before pregnancy. This study also found no clear increase in the risk of miscarriage, congenital abnormalities or low or high birth weight. However, the researchers emphasise that the estimates are uncertain.
What does this mean for you?
These results are reassuring for women who discovered they were pregnant whilst taking semaglutide. They do not mean that the medicine is safe during pregnancy. These are observational studies, involving relatively small groups and mainly data from the first few weeks. The official advice therefore remains the same: do not use semaglutide if you are pregnant.
Unexpectedly pregnant whilst taking Ozempic?
If you discover you are pregnant whilst undergoing treatment, stop taking semaglutide. You should then contact the doctor supervising your treatment, as well as your GP or midwife. They can discuss with you what steps need to be taken.
If you have type 2 diabetes, do not simply stop taking all your medication. Keeping your blood sugar under control is particularly important during pregnancy. Treatment is usually switched to insulin. You should always do this in consultation with your doctor.
Ozempic and trying for a baby: how do you prepare?
Are you planning to have a baby and are you taking semaglutide? If so, it is advisable to plan your pregnancy carefully in advance. When it comes to Ozempic and getting pregnant, three factors are important: when to stop taking it, contraception and your weight.
Stop at least 2 months before you plan to become pregnant
Semaglutide has a long half-life of around a week. This means that the medicine remains in your body for weeks after your last injection. It is only after around five weeks that it has largely cleared from your blood.
That is why the official advice is: stop taking it at least two months before you plan to become pregnant. This minimises the chance that there will still be semaglutide in your body by the time you become pregnant. Always discuss when to stop taking the medication with your doctor. They can also advise you on how to keep your weight as stable as possible during this period.
Contraception during your treatment
Women of childbearing age are advised to use contraception whilst taking semaglutide. According to the product information, semaglutide does not reduce the effectiveness of the contraceptive pill.
There is, however, one point to bear in mind. If you vomit within a few hours of taking the pill, or if you have severe diarrhoea, the pill may be less reliable. This applies regardless of which medicine you are taking. As nausea and vomiting can be side effects of semaglutide, it is good to be aware of this. In that case, follow the instructions in your pill’s patient information leaflet.
Are you taking tirzepatide (Mounjaro) instead of semaglutide? Different advice applies regarding the pill in this case. Please discuss this with your doctor.
Why some women become pregnant unexpectedly
The media sometimes refer to ‘Ozempic babies’: pregnancies that occur whilst women are taking GLP-1 medication. There is a logical explanation for this, although it has not yet been fully investigated.
Being overweight can disrupt hormone balance and cause irregular ovulation. This is seen, for example, in PCOS, a hormonal condition that is often associated with being overweight. Weight loss can restore ovulation. Women who thought they would struggle to conceive may therefore suddenly find themselves more fertile. The effect of semaglutide itself on human fertility is not known. It is primarily the weight loss that appears to play a role.
This is also good news. For many women who are overweight, losing weight can increase their chances of becoming pregnant. That is precisely why it is important to use effective contraception during treatment, until you consciously decide to become pregnant.
What happens to your weight when you stop?
Many women are concerned about stopping semaglutide. This concern is understandable. After stopping the treatment, appetite often returns and some of the weight lost may be regained.
A US study published in JAMA in 2025 examined nearly 1,800 pregnancies. Women who had stopped taking GLP-1 medication shortly before or early in their pregnancy gained, on average, over 3 kilos more during pregnancy than women who had never used the drug. They were also more likely to develop gestational diabetes, high blood pressure and to give birth prematurely. The researchers emphasise that further research is needed. It does, however, show that guidance on stopping the medication is important.
The good news is that you’ll carry forward what you’ve learnt during your programme. Think of things like eating at regular intervals, being mindful of portion sizes, getting enough exercise and sleeping well. These habits will help you keep weight gain to a minimum, even without medication.
Why a healthy weight is important before pregnancy
Achieving a healthier weight before pregnancy has benefits for both you and your baby. Obesity increases the risk of gestational diabetes, high blood pressure and complications during childbirth. Losing weight before pregnancy can reduce these risks.
Semaglutide can therefore play a valuable role in the period leading up to trying for a baby. This is on condition that it is taken under medical supervision and that treatment is stopped in good time. A doctor can work with you to draw up a plan that suits your situation and your timeline.
Ozempic after pregnancy
After giving birth, many women want to get back on track with their weight. Even then, it’s good to know what you can and can’t do. When it comes to Ozempic after pregnancy, the main considerations are breastfeeding and the time your body needs to recover.
Ozempic and breastfeeding
Semaglutide is not recommended whilst breastfeeding. In rats, semaglutide passes into breast milk. As a risk to the baby cannot be ruled out, the official advice is not to use this medicine whilst you are breastfeeding.
A small study from 2024 involved eight women who were using semaglutide whilst breastfeeding. No semaglutide was detected in their breast milk. This is an initial indication that the transfer into breast milk is limited. However, the study is too small to draw any conclusions. The advice not to use semaglutide whilst breastfeeding therefore remains in place.
When can you start again?
Are you not breastfeeding, or have you stopped? If so, treatment with semaglutide may be an option again. A doctor will first assess your health, your weight and your recovery after giving birth. If you wish to become pregnant again in the foreseeable future, this will also be taken into account in the treatment plan.
Give your body time
After pregnancy, your body needs time to recover. Sleepless nights, hormonal changes and looking after a baby make it difficult to focus on your weight. It’s normal for the weight not to come off straight away. So be kind to yourself. Small, achievable steps often work better in the long run than a strict plan that you can’t stick to.
Practical advice on Ozempic and planning a family
- Discuss your plans to have children with your doctor in good time. This way, you can plan when to stop together and choose an approach that suits your situation.
- Stop at least two months before you want to get pregnant. Until then, use reliable contraception.
- Start taking folic acid in good time. The advice is to start as soon as you are planning to become pregnant, even if you are still taking semaglutide or have only just stopped.
- Keep up the habits you’ve developed. Eating regularly, getting enough exercise and sleeping well help to keep your weight stable after you’ve stopped.
Frequently asked questions about Ozempic and pregnancy
Can you take Ozempic whilst pregnant? No. There is insufficient data on safety in pregnant women, and harmful effects have been observed in animal studies. The advice is not to use semaglutide if you are pregnant.
How far in advance should you stop taking Ozempic if you’re planning to get pregnant? It is recommended that you stop taking it at least two months before you plan to become pregnant. This is because semaglutide remains in your body for several weeks after the last injection.
I’m pregnant and was taking Ozempic. Is that dangerous? Stop taking the medicine and contact your doctor or midwife. Research to date does not show a clearly increased risk of birth defects when taken during the first few weeks. However, the data available is limited.
Can Ozempic make you more fertile? The effect of semaglutide itself on fertility is not known. However, weight loss can improve ovulation, particularly in women who are overweight or have PCOS. You should therefore use reliable contraception during your treatment.
Can you take Ozempic whilst breastfeeding? No, it is not recommended. A small study found no traces of semaglutide in breast milk, but that is not enough evidence. Once you have stopped breastfeeding, a doctor can assess whether treatment is appropriate again.
Key insights
- Ozempic (semaglutide) is not recommended during pregnancy, as there is insufficient data on its safety and animal studies have shown harmful effects.
- Anyone wishing to become pregnant should stop taking semaglutide at least two months before planning a pregnancy, due to the drug’s long half-life.
- Large observational studies do not show a clear increased risk of congenital abnormalities when used in the first few weeks of pregnancy, but the evidence is still limited.
- Weight loss can improve fertility, which is why it is important to use reliable contraception whilst undergoing treatment with semaglutide.
- Semaglutide is also not recommended whilst breastfeeding. Once breastfeeding has stopped, a doctor can assess whether a new treatment is appropriate.
Would you like to work towards a healthier weight, for example as part of preparing to start a family? At WeightConsult, a doctor will assess on a one-to-one basis whether medical support is suitable for you and your plans.
Key points blog
Can you take Ozempic if you’re pregnant?
Can you take Ozempic if you’re pregnant?
No. Semaglutide is not recommended during pregnancy and whilst breastfeeding. If you become pregnant unexpectedly, stop taking it and contact your doctor.
When should you stop taking Ozempic if you’re trying to get pregnant?
When should you stop taking Ozempic if you’re trying to get pregnant?
At least 2 months before you plan to become pregnant. The medication remains in your body for several weeks. Use reliable contraception until then.
How do you keep your weight stable when you stop eating in preparation for pregnancy?
How do you keep your weight stable when you stop eating in preparation for pregnancy?
Plan your weaning off the medication together with your doctor and stick to the healthy habits you’ve developed during your treatment. This will help minimise the risk of excessive weight gain during pregnancy.
Sources:
- European Medicines Agency. Ozempic: EPAR, product information (sections 4.5 and 4.6). ema.europa.eu
- Cesta CE, et al. Safety of GLP-1 receptor agonists and other second-line antidiabetics in early pregnancy. JAMA Internal Medicine. 2024. jamanetwork.com
- Brown JP, et al. Continuing Glucagon-Like Peptide-1 Receptor Agonists into the First Trimester of Pregnancy and Pregnancy Outcomes: A Target Trial Emulation Study Using Claims Data. Annals of Internal Medicine. 2026. pubmed.ncbi.nlm.nih.gov/42258827
- Maya J, et al. Gestational Weight Gain and Pregnancy Outcomes Following Discontinuation of GLP-1 Receptor Agonists. JAMA. 2025. pubmed.ncbi.nlm.nih.gov/41284263
- Diab H, et al. Subcutaneous Semaglutide during Breastfeeding: Infant Safety Regarding Drug Transfer into Human Milk. Nutrients. 2024. pubmed.ncbi.nlm.nih.gov/39275201